Hem › Hjärt-kärlsjukdom › Tennessee › Nashville
Kliniska studier för Hjärt-kärlsjukdom i Nashville, TN
18 studier för Hjärt-kärlsjukdom söker deltagare vid platser i och runt Nashville (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RekryterarFas 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Rekryterar
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Rekryterar
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
RekryterarObservationsstudie
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekryterar
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekryterarFas 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Rekryterar
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RekryterarFas 4Friska volontärer välkomna
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RekryterarFas 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekryterarFas 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekryterarFas 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
RekryterarObservationsstudie
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekryterar
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
RekryterarFas 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekryterar
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
RekryterarFas 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
RekryterarObservationsstudie
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Rekryterar
- Centennial Medical Center, Nashville
Hjärt-kärlsjukdom-studier i andra städer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Cleveland, OH22 studier
- Atlanta, GA22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- San Francisco, CA18 studier
Andra studier i Nashville
- Icke-småcellig lungcancer97 studier
- Bröstcancer81 studier
- Metastaserande cancer70 studier
- Kolorektal cancer69 studier
- Cancer (alla typer)65 studier
- Äggstockscancer49 studier
- Prostatacancer43 studier
- Lungcancer40 studier
- Plattenepitelcancer i huvud och hals39 studier
- Bukspottkörtelcancer39 studier
- Endometriecancer38 studier
- Melanom33 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.